This work was supported by the Max Schaldach Fellowship in Cardiac Pacing and Electrophysiology (P.A.N.), the NIH/NHLBI (HL080025, HL098283 C.N.-C.), the Doris Duke Charitable Foundation (C.N.-C.), and the Burroughs Wellcome Fund (C.N.-C.). The FHS was supported by the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine (Contract No. N01-HC-25195).
QT Interval and Long-Term Mortality Risk in the Framingham Heart Study
Article first published online: 13 AUG 2012
© 2012, Wiley Periodicals, Inc.
Annals of Noninvasive Electrocardiology
Volume 17, Issue 4, pages 340–348, October 2012
How to Cite
Noseworthy, P. A., Peloso, G. M., Hwang, S.-J., Larson, M. G., Levy, D., O’Donnell, C. J. and Newton-Cheh, C. (2012), QT Interval and Long-Term Mortality Risk in the Framingham Heart Study. Annals of Noninvasive Electrocardiology, 17: 340–348. doi: 10.1111/j.1542-474X.2012.00535.x
The authors report no relationships with industry relevant to this work. Dr. Newton-Cheh is on a Merck scientific advisory board.
- Issue published online: 25 OCT 2012
- Article first published online: 13 AUG 2012
Supplemental Table 1. Mean and range QTC (millisecond) by QTLR quintile and QTC quintile.
|ANEC_535_sm_suppmat.doc||402K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.